Free Trial

BlueLinx (BXC) Financials

BlueLinx logo
$72.08 +2.00 (+2.85%)
As of 02:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for BlueLinx

Annual Income Statements for BlueLinx

This table shows BlueLinx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
296 49 53
Consolidated Net Income / (Loss)
296 49 53
Net Income / (Loss) Continuing Operations
296 49 53
Total Pre-Tax Income
395 82 71
Total Operating Income
439 138 88
Total Gross Profit
833 527 489
Total Revenue
4,450 3,136 2,953
Operating Revenue
4,450 3,136 2,953
Total Cost of Revenue
3,617 2,609 2,463
Operating Cost of Revenue
3,617 2,609 2,463
Total Operating Expenses
394 389 402
Selling, General & Admin Expense
370 360 367
Depreciation Expense
28 32 38
Other Operating Expenses / (Income)
- -3.93 -3.93
Other Special Charges / (Income)
-0.14 0.00 -0.27
Total Other Income / (Expense), net
-44 -57 -17
Interest & Investment Income
-42 -24 -19
Other Income / (Expense), net
-2.05 -33 2.48
Income Tax Expense
99 33 18
Basic Earnings per Share
$31.75 $5.40 $6.22
Weighted Average Basic Shares Outstanding
9.06M 8.65M 8.29M
Diluted Earnings per Share
$31.51 $5.39 $6.19
Weighted Average Diluted Shares Outstanding
9.06M 8.65M 8.29M
Weighted Average Basic & Diluted Shares Outstanding
9.06M 8.65M 8.29M

Quarterly Income Statements for BlueLinx

This table shows BlueLinx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
60 32 18 24 24 -18 17 14 16 5.27
Consolidated Net Income / (Loss)
60 32 18 24 24 -18 17 14 16 5.27
Net Income / (Loss) Continuing Operations
60 32 18 24 24 -18 17 14 16 5.27
Total Pre-Tax Income
81 41 24 32 33 -8.02 23 19 22 6.97
Total Operating Income
91 51 33 39 40 27 28 24 24 12
Total Gross Profit
189 151 134 136 139 118 128 122 126 113
Total Revenue
1,061 848 798 816 810 713 726 768 747 711
Operating Revenue
1,061 848 798 816 810 713 726 768 747 711
Total Cost of Revenue
871 697 664 680 671 594 599 646 622 597
Operating Cost of Revenue
871 697 664 680 671 594 599 646 622 597
Total Operating Expenses
99 100 101 97 100 91 100 99 102 101
Selling, General & Admin Expense
93 93 94 90 92 84 92 89 93 93
Depreciation Expense
6.69 7.66 7.72 7.95 8.09 8.29 9.43 10 9.53 9.41
Other Operating Expenses / (Income)
-0.98 - -0.98 -0.98 -0.98 -0.98 -0.98 -0.98 -0.98 -0.98
Total Other Income / (Expense), net
-10 -12 -8.28 -6.91 -6.17 -35 -4.62 -4.80 -2.39 -5.07
Other Income / (Expense), net
0.36 - -0.59 -0.59 -0.59 -31 0.00 0.00 2.23 0.26
Income Tax Expense
21 8.74 6.42 7.72 9.10 10 5.55 4.71 5.62 1.69
Basic Earnings per Share
$6.44 $3.95 $1.96 $2.70 $2.72 ($1.98) $2.02 $1.65 $1.88 $0.67
Weighted Average Basic Shares Outstanding
9.04M 9.06M 9.09M 9.00M 8.77M 8.65M 8.66M 8.53M 8.38M 8.29M
Diluted Earnings per Share
$6.38 $4.46 $1.94 $2.70 $2.71 ($1.96) $2.00 $1.65 $1.87 $0.67
Weighted Average Diluted Shares Outstanding
9.04M 9.06M 9.09M 9.00M 8.77M 8.65M 8.66M 8.53M 8.38M 8.29M
Weighted Average Basic & Diluted Shares Outstanding
9.04M 9.06M 9.09M 9.00M 8.77M 8.65M 8.66M 8.53M 8.38M 8.29M

Annual Cash Flow Statements for BlueLinx

This table details how cash moves in and out of BlueLinx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Change in Cash & Equivalents
214 223 -16
Net Cash From Operating Activities
400 306 85
Net Cash From Continuing Operating Activities
400 306 85
Net Income / (Loss) Continuing Operations
296 49 53
Consolidated Net Income / (Loss)
296 49 53
Depreciation Expense
28 32 38
Amortization Expense
-2.78 -2.62 -2.62
Non-Cash Adjustments To Reconcile Net Income
9.47 42 7.48
Changes in Operating Assets and Liabilities, net
70 187 -11
Net Cash From Investing Activities
-99 -27 -39
Net Cash From Continuing Investing Activities
-99 -27 -39
Purchase of Property, Plant & Equipment
-36 -28 -40
Acquisitions
-64 0.30 0.00
Sale of Property, Plant & Equipment
0.96 0.36 0.90
Net Cash From Financing Activities
-88 -57 -62
Net Cash From Continuing Financing Activities
-88 -57 -62
Repurchase of Common Equity
-66 -42 -45
Other Financing Activities, net
-21 -14 -17
Cash Interest Paid
44 43 45
Cash Income Taxes Paid
111 19 30

Quarterly Cash Flow Statements for BlueLinx

This table details how cash moves in and out of BlueLinx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
124 70 77 42 51 52 -40 10 35 -21
Net Cash From Operating Activities
143 154 89 64 78 76 -31 36 62 19
Net Cash From Continuing Operating Activities
143 154 89 64 78 76 -31 36 62 19
Net Income / (Loss) Continuing Operations
60 32 18 24 24 -18 17 14 16 5.27
Consolidated Net Income / (Loss)
60 32 18 24 24 -18 17 14 16 5.27
Depreciation Expense
6.69 7.66 7.72 7.95 8.09 8.29 9.43 10 9.53 9.41
Amortization Expense
-0.65 -0.65 -0.66 -0.65 -0.65 -0.65 -0.65 -0.65 -0.65 -0.65
Non-Cash Adjustments To Reconcile Net Income
2.09 3.59 4.57 1.93 2.98 32 2.35 1.41 0.96 2.76
Changes in Operating Assets and Liabilities, net
75 112 60 30 43 54 -60 11 36 1.96
Net Cash From Investing Activities
-12 -80 -8.97 -4.94 -4.84 -8.12 -5.32 -6.31 -7.36 -20
Net Cash From Continuing Investing Activities
-12 -80 -8.97 -4.94 -4.84 -8.12 -5.32 -6.31 -7.36 -20
Purchase of Property, Plant & Equipment
-12 -17 -9.01 -5.03 -4.90 -8.58 -5.45 -6.45 -7.93 -20
Sale of Property, Plant & Equipment
0.12 0.32 0.04 0.09 0.06 0.17 0.13 0.15 0.57 0.06
Net Cash From Financing Activities
-6.11 -4.42 -2.70 -17 -21 -15 -3.98 -19 -20 -19
Net Cash From Continuing Financing Activities
-6.11 -4.42 -2.70 -17 -21 -15 -3.98 -19 -20 -19
Repurchase of Common Equity
- - - - -18 -13 - - -15 -15
Other Financing Activities, net
-6.11 -4.42 -2.70 -5.52 -3.59 -2.67 -3.98 -4.88 -4.06 -3.87
Cash Interest Paid
2.12 19 6.19 15 6.48 15 6.80 15 6.88 16
Cash Income Taxes Paid
29 21 0.00 11 6.86 1.56 1.34 21 2.13 6.18

Annual Balance Sheets for BlueLinx

This table presents BlueLinx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Total Assets
1,490 1,538 1,578
Total Current Assets
1,077 1,120 1,134
Cash & Equivalents
299 522 506
Accounts Receivable
252 228 226
Inventories, net
484 344 356
Other Current Assets
42 27 47
Plant, Property, & Equipment, net
206 226 250
Total Noncurrent Assets
208 191 194
Goodwill
55 55 55
Intangible Assets
35 31 27
Noncurrent Deferred & Refundable Income Taxes
56 53 51
Other Noncurrent Operating Assets
61 52 61
Total Liabilities & Shareholders' Equity
1,490 1,538 1,578
Total Liabilities
900 903 931
Total Current Liabilities
211 219 234
Accounts Payable
152 158 170
Current Deferred Revenue
3.94 3.94 3.94
Current Employee Benefit Liabilities
23 14 17
Other Current Liabilities
33 42 43
Total Noncurrent Liabilities
689 685 698
Long-Term Debt
292 294 295
Other Noncurrent Operating Liabilities
397 391 402
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
590 634 646
Total Preferred & Common Equity
590 634 646
Preferred Stock
0.00 0.00 0.00
Total Common Equity
590 634 646
Common Stock
201 165 124
Retained Earnings
421 469 522

Quarterly Balance Sheets for BlueLinx

This table presents BlueLinx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
1,534 1,526 1,550 1,585 1,592 1,586 1,611
Total Current Assets
1,158 1,114 1,137 1,171 1,173 1,159 1,181
Cash & Equivalents
229 376 418 470 481 491 526
Accounts Receivable
361 299 294 298 288 274 278
Inventories, net
536 409 379 364 371 358 341
Other Current Assets
32 29 45 40 32 36 37
Plant, Property, & Equipment, net
189 208 210 216 231 232 236
Plant, Property & Equipment, gross
340 366 374 382 407 414 424
Accumulated Depreciation
151 158 163 166 176 182 188
Total Noncurrent Assets
187 204 203 199 188 195 194
Goodwill
48 55 55 55 55 55 55
Intangible Assets
11 34 33 32 30 29 28
Noncurrent Deferred & Refundable Income Taxes
61 56 56 55 54 54 51
Other Noncurrent Operating Assets
66 59 59 57 49 57 59
Total Liabilities & Shareholders' Equity
1,534 1,526 1,550 1,585 1,592 1,586 1,611
Total Liabilities
976 915 928 954 938 934 955
Total Current Liabilities
273 228 245 268 249 237 258
Accounts Payable
208 177 190 202 172 179 186
Current Deferred Revenue
- 3.94 3.94 3.94 3.94 3.94 3.94
Current Employee Benefit Liabilities
18 15 16 21 14 12 18
Other Current Liabilities
40 32 34 41 60 42 49
Total Noncurrent Liabilities
703 687 683 686 689 696 698
Long-Term Debt
292 293 293 293 294 294 295
Other Noncurrent Operating Liabilities
330 394 390 393 395 402 403
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
558 611 623 632 653 652 656
Total Preferred & Common Equity
558 611 623 632 653 652 656
Preferred Stock
- - - - 0.00 0.00 0.00
Total Common Equity
558 611 623 632 653 652 656
Common Stock
198 204 191 175 167 151 139
Retained Earnings
389 438 463 487 487 501 517

Annual Metrics and Ratios for BlueLinx

This table displays calculated financial ratios and metrics derived from BlueLinx's official financial filings.

Metric 2022 2023 2024
Growth Metrics
- - -
Revenue Growth
4.05% -29.52% -5.86%
EBITDA Growth
-0.69% -70.76% -6.77%
EBIT Growth
-0.53% -75.83% -14.75%
NOPAT Growth
0.02% -75.09% -19.81%
Net Income Growth
0.01% -83.61% 9.44%
EPS Growth
5.07% -82.89% 14.84%
Operating Cash Flow Growth
176.02% -23.49% -72.19%
Free Cash Flow Firm Growth
122.79% -17.75% -86.04%
Invested Capital Growth
2.49% -30.37% 7.28%
Revenue Q/Q Growth
-2.74% -4.13% -0.06%
EBITDA Q/Q Growth
-11.47% -29.37% 15.88%
EBIT Q/Q Growth
-12.29% -34.96% 21.83%
NOPAT Q/Q Growth
-11.43% -33.09% 20.05%
Net Income Q/Q Growth
-12.32% -50.80% 78.72%
EPS Q/Q Growth
-8.43% -54.36% 73.88%
Operating Cash Flow Q/Q Growth
51.51% -20.44% -40.01%
Free Cash Flow Firm Q/Q Growth
22.70% -27.83% -57.85%
Invested Capital Q/Q Growth
-15.65% -10.73% 2.79%
Profitability Metrics
- - -
Gross Margin
18.72% 16.80% 16.57%
EBITDA Margin
10.38% 4.31% 4.26%
Operating Margin
9.87% 4.41% 2.97%
EBIT Margin
9.82% 3.37% 3.05%
Profit (Net Income) Margin
6.66% 1.55% 1.80%
Tax Burden Percent
75.03% 59.27% 75.14%
Interest Burden Percent
90.33% 77.52% 78.50%
Effective Tax Rate
24.97% 40.73% 24.86%
Return on Invested Capital (ROIC)
57.15% 16.58% 15.63%
ROIC Less NNEP Spread (ROIC-NNEP)
23.82% 45.17% 21.41%
Return on Net Nonoperating Assets (RNNOA)
4.99% -8.65% -7.33%
Return on Equity (ROE)
62.14% 7.93% 8.29%
Cash Return on Invested Capital (CROIC)
54.69% 52.39% 8.60%
Operating Return on Assets (OROA)
31.13% 6.98% 5.78%
Return on Assets (ROA)
21.10% 3.21% 3.41%
Return on Common Equity (ROCE)
62.14% 7.93% 8.29%
Return on Equity Simple (ROE_SIMPLE)
50.20% 7.65% 8.22%
Net Operating Profit after Tax (NOPAT)
329 82 66
NOPAT Margin
7.40% 2.62% 2.23%
Net Nonoperating Expense Percent (NNEP)
33.33% -28.59% -5.79%
Return On Investment Capital (ROIC_SIMPLE)
37.33% 8.84% 6.99%
Cost of Revenue to Revenue
81.28% 83.20% 83.43%
SG&A Expenses to Revenue
8.32% 11.49% 12.44%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
8.85% 12.39% 13.60%
Earnings before Interest and Taxes (EBIT)
437 106 90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
462 135 126
Valuation Ratios
- - -
Price to Book Value (P/BV)
1.09 1.57 1.34
Price to Tangible Book Value (P/TBV)
1.29 1.81 1.54
Price to Revenue (P/Rev)
0.14 0.32 0.29
Price to Earnings (P/E)
2.17 20.47 16.37
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
46.10% 4.89% 6.11%
Enterprise Value to Invested Capital (EV/IC)
1.09 1.88 1.51
Enterprise Value to Revenue (EV/Rev)
0.14 0.24 0.22
Enterprise Value to EBITDA (EV/EBITDA)
1.38 5.67 5.23
Enterprise Value to EBIT (EV/EBIT)
1.46 7.25 7.31
Enterprise Value to NOPAT (EV/NOPAT)
1.93 9.33 10.01
Enterprise Value to Operating Cash Flow (EV/OCF)
1.59 2.50 7.73
Enterprise Value to Free Cash Flow (EV/FCFF)
2.02 2.95 18.19
Leverage & Solvency
- - -
Debt to Equity
0.50 0.46 0.46
Long-Term Debt to Equity
0.50 0.46 0.46
Financial Leverage
0.21 -0.19 -0.34
Leverage Ratio
2.95 2.47 2.43
Compound Leverage Factor
2.66 1.92 1.91
Debt to Total Capital
33.14% 31.65% 31.34%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
33.14% 31.65% 31.34%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
66.86% 68.35% 68.66%
Debt to EBITDA
0.63 2.17 2.34
Net Debt to EBITDA
-0.01 -1.69 -1.67
Long-Term Debt to EBITDA
0.63 2.17 2.34
Debt to NOPAT
0.89 3.58 4.48
Net Debt to NOPAT
-0.02 -2.78 -3.20
Long-Term Debt to NOPAT
0.89 3.58 4.48
Altman Z-Score
5.48 4.06 3.77
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
5.11 5.13 4.85
Quick Ratio
2.61 3.43 3.13
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
315 259 36
Operating Cash Flow to CapEx
1,146.26% 1,127.58% 217.24%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00
Efficiency Ratios
- - -
Asset Turnover
3.17 2.07 1.90
Accounts Receivable Turnover
15.06 13.07 13.00
Inventory Turnover
7.44 6.30 7.04
Fixed Asset Turnover
0.00 14.53 12.42
Accounts Payable Turnover
21.82 16.86 15.01
Days Sales Outstanding (DSO)
24.24 27.93 28.08
Days Inventory Outstanding (DIO)
49.08 57.91 51.83
Days Payable Outstanding (DPO)
16.73 21.65 24.31
Cash Conversion Cycle (CCC)
56.59 64.18 55.59
Capital & Investment Metrics
- - -
Invested Capital
584 406 436
Invested Capital Turnover
7.72 6.34 7.01
Increase / (Decrease) in Invested Capital
14 -177 30
Enterprise Value (EV)
636 765 659
Market Capitalization
643 993 869
Book Value per Share
$65.30 $72.35 $77.13
Tangible Book Value per Share
$55.30 $62.52 $67.32
Total Capital
882 928 942
Total Debt
292 294 295
Total Long-Term Debt
292 294 295
Net Debt
-6.52 -228 -211
Capital Expenditures (CapEx)
35 27 39
Debt-free, Cash-free Net Working Capital (DFCFNWC)
567 380 395
Debt-free Net Working Capital (DFNWC)
866 902 900
Net Working Capital (NWC)
866 902 900
Net Nonoperating Expense (NNE)
33 34 13
Net Nonoperating Obligations (NNO)
-6.52 -228 -211
Total Depreciation and Amortization (D&A)
25 29 36
Debt-free, Cash-free Net Working Capital to Revenue
12.75% 12.12% 13.37%
Debt-free Net Working Capital to Revenue
19.47% 28.75% 30.49%
Net Working Capital to Revenue
19.47% 28.75% 30.49%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$31.75 $5.40 $6.22
Adjusted Weighted Average Basic Shares Outstanding
9.06M 8.65M 8.29M
Adjusted Diluted Earnings per Share
$31.51 $5.39 $6.19
Adjusted Weighted Average Diluted Shares Outstanding
9.06M 8.65M 8.29M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
9.06M 8.65M 8.29M
Normalized Net Operating Profit after Tax (NOPAT)
329 82 66
Normalized NOPAT Margin
7.40% 2.62% 2.22%
Pre Tax Income Margin
8.87% 2.61% 2.39%
Debt Service Ratios
- - -
EBIT to Interest Expense
0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
22.43% 86.81% 85.28%

Quarterly Metrics and Ratios for BlueLinx

This table displays calculated financial ratios and metrics derived from BlueLinx's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
9.26% -12.87% -38.73% -34.16% -23.64% -15.95% -8.98% -5.83% -7.74% -0.27%
EBITDA Growth
24.24% -49.83% -80.43% -58.25% -52.13% -93.49% -6.51% -27.26% -24.45% 456.07%
EBIT Growth
26.96% -53.63% -83.47% -62.95% -57.12% -107.53% -13.32% -38.06% -32.80% 419.09%
NOPAT Growth
26.65% -51.29% -83.24% -62.87% -56.87% -52.63% -12.12% -39.59% -38.40% -52.15%
Net Income Growth
26.08% -56.55% -86.65% -65.67% -59.03% -156.66% -1.80% -41.40% -34.31% 129.09%
EPS Growth
34.60% -39.40% -85.29% -63.90% -57.52% -143.95% 3.09% -38.89% -31.00% 134.18%
Operating Cash Flow Growth
36.78% 749.27% 3,876.98% -36.60% -45.58% -51.02% -135.00% -44.19% -20.41% -75.19%
Free Cash Flow Firm Growth
54.65% 124.65% 1,906.97% 665.52% 652.09% 655.55% -60.04% -79.34% -81.59% -110.44%
Invested Capital Growth
19.95% 2.49% -25.66% -34.44% -34.21% -30.37% -11.62% -8.48% -6.83% 7.28%
Revenue Q/Q Growth
-14.41% -20.08% -5.88% 2.26% -0.73% -12.03% 1.92% 5.80% -2.74% -4.90%
EBITDA Q/Q Growth
-11.45% -40.12% -32.96% 17.47% 1.53% -91.86% 863.44% -8.60% 5.45% -40.11%
EBIT Q/Q Growth
-12.34% -43.85% -37.59% 20.61% 1.46% -109.86% 818.65% -13.81% 10.08% -53.20%
NOPAT Q/Q Growth
-16.35% -40.00% -40.50% 24.34% -2.82% -34.10% 10.37% -14.53% -0.90% -48.81%
Net Income Q/Q Growth
-16.50% -46.25% -44.31% 37.36% -0.34% -174.33% 196.51% -18.04% 11.72% -67.08%
EPS Q/Q Growth
-14.71% -30.09% -56.50% 39.18% 0.37% -172.32% 202.04% -17.50% 13.33% -64.17%
Operating Cash Flow Q/Q Growth
40.92% 8.17% -42.33% -27.89% 20.97% -2.64% -141.21% 214.99% 72.52% -69.65%
Free Cash Flow Firm Q/Q Growth
6.54% 154.01% 692.69% 41.34% -8.76% -26.09% -58.07% -26.92% -18.70% -141.91%
Invested Capital Q/Q Growth
-8.84% -15.65% -9.64% -5.64% -8.52% -10.73% 14.69% -2.28% -6.87% 2.79%
Profitability Metrics
- - - - - - - - - -
Gross Margin
17.85% 17.83% 16.74% 16.64% 17.19% 16.62% 17.58% 15.94% 16.82% 15.95%
EBITDA Margin
9.16% 6.86% 4.89% 5.61% 5.74% 0.53% 5.02% 4.34% 4.70% 2.96%
Operating Margin
8.55% 6.03% 4.08% 4.79% 4.90% 3.82% 3.81% 3.10% 3.22% 1.69%
EBIT Margin
8.59% 6.03% 4.00% 4.72% 4.82% -0.54% 3.81% 3.10% 3.51% 1.73%
Profit (Net Income) Margin
5.61% 3.77% 2.23% 3.00% 3.01% -2.54% 2.41% 1.87% 2.14% 0.74%
Tax Burden Percent
73.79% 78.54% 73.50% 76.01% 72.81% 225.96% 75.91% 75.27% 74.04% 75.69%
Interest Burden Percent
88.53% 79.63% 75.92% 83.61% 85.72% 208.34% 83.29% 79.87% 82.40% 56.70%
Effective Tax Rate
26.21% 21.46% 26.50% 23.99% 27.19% 0.00% 24.09% 24.73% 25.96% 24.31%
Return on Invested Capital (ROIC)
45.53% 36.58% 19.12% 20.42% 20.34% 16.93% 17.85% 14.79% 16.00% 8.98%
ROIC Less NNEP Spread (ROIC-NNEP)
42.06% 28.38% 10.00% 12.58% 41.59% 48.61% 20.44% 17.04% 16.87% 10.73%
Return on Net Nonoperating Assets (RNNOA)
21.46% 5.94% 1.21% 1.50% -1.48% -9.31% -4.38% -4.31% -5.35% -3.68%
Return on Equity (ROE)
66.99% 42.52% 20.33% 21.92% 18.86% 7.61% 13.47% 10.49% 10.65% 5.31%
Cash Return on Invested Capital (CROIC)
40.51% 54.69% 63.57% 67.17% 62.65% 52.39% 28.41% 22.86% 19.54% 8.60%
Operating Return on Assets (OROA)
28.72% 19.13% 10.32% 10.86% 10.12% -1.12% 7.49% 5.97% 6.49% 3.28%
Return on Assets (ROA)
18.76% 11.96% 5.76% 6.90% 6.31% -5.27% 4.74% 3.59% 3.96% 1.41%
Return on Common Equity (ROCE)
66.99% 42.52% 20.33% 21.92% 18.86% 7.61% 13.47% 10.49% 10.65% 5.31%
Return on Equity Simple (ROE_SIMPLE)
60.57% 0.00% 29.57% 21.48% 15.62% 0.00% 7.38% 5.84% 4.53% 0.00%
Net Operating Profit after Tax (NOPAT)
67 40 24 30 29 19 21 18 18 9.11
NOPAT Margin
6.31% 4.74% 3.00% 3.64% 3.56% 2.67% 2.89% 2.34% 2.38% 1.28%
Net Nonoperating Expense Percent (NNEP)
3.47% 8.20% 9.11% 7.84% -21.25% -31.68% -2.59% -2.24% -0.87% -1.75%
Return On Investment Capital (ROIC_SIMPLE)
- 4.55% - - - 2.05% - - - 0.97%
Cost of Revenue to Revenue
82.15% 82.17% 83.26% 83.36% 82.81% 83.38% 82.42% 84.06% 83.18% 84.05%
SG&A Expenses to Revenue
8.76% 11.01% 11.82% 11.00% 11.42% 11.78% 12.61% 11.64% 12.46% 13.11%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
9.30% 11.80% 12.66% 11.85% 12.30% 12.81% 13.77% 12.83% 13.60% 14.26%
Earnings before Interest and Taxes (EBIT)
91 51 32 38 39 -3.85 28 24 26 12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
97 58 39 46 46 3.78 36 33 35 21
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.03 1.09 1.01 1.37 1.17 1.57 1.75 1.24 1.36 1.34
Price to Tangible Book Value (P/TBV)
1.16 1.29 1.18 1.59 1.36 1.81 2.01 1.42 1.56 1.54
Price to Revenue (P/Rev)
0.13 0.14 0.16 0.24 0.23 0.32 0.37 0.27 0.30 0.29
Price to Earnings (P/E)
1.71 2.17 3.41 6.37 7.49 20.47 23.68 21.17 29.99 16.37
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
58.60% 46.10% 29.33% 15.69% 13.35% 4.89% 4.22% 4.72% 3.33% 6.11%
Enterprise Value to Invested Capital (EV/IC)
1.03 1.09 1.01 1.46 1.24 1.88 2.05 1.34 1.56 1.51
Enterprise Value to Revenue (EV/Rev)
0.16 0.14 0.13 0.21 0.17 0.24 0.31 0.20 0.22 0.22
Enterprise Value to EBITDA (EV/EBITDA)
1.36 1.38 1.75 3.02 2.94 5.67 7.20 5.08 6.07 5.23
Enterprise Value to EBIT (EV/EBIT)
1.43 1.46 1.91 3.41 3.46 7.25 9.42 7.03 8.93 7.31
Enterprise Value to NOPAT (EV/NOPAT)
1.91 1.93 2.52 4.53 4.59 9.33 11.96 9.13 12.04 10.01
Enterprise Value to Operating Cash Flow (EV/OCF)
2.69 1.59 1.09 1.62 1.46 2.50 5.13 3.86 4.65 7.73
Enterprise Value to Free Cash Flow (EV/FCFF)
2.77 2.02 1.35 1.72 1.57 2.95 6.76 5.59 7.68 18.19
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.65 0.50 0.48 0.47 0.46 0.46 0.45 0.45 0.45 0.46
Long-Term Debt to Equity
0.65 0.50 0.48 0.47 0.46 0.46 0.45 0.45 0.45 0.46
Financial Leverage
0.51 0.21 0.12 0.12 -0.04 -0.19 -0.21 -0.25 -0.32 -0.34
Leverage Ratio
3.26 2.95 2.77 2.73 2.62 2.47 2.47 2.46 2.48 2.43
Compound Leverage Factor
2.88 2.35 2.11 2.28 2.25 5.15 2.05 1.96 2.05 1.38
Debt to Total Capital
39.46% 33.14% 32.40% 32.00% 31.72% 31.65% 31.04% 31.10% 31.01% 31.34%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
39.46% 33.14% 32.40% 32.00% 31.72% 31.65% 31.04% 31.10% 31.01% 31.34%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
60.54% 66.86% 67.60% 68.00% 68.28% 68.35% 68.96% 68.90% 68.99% 68.66%
Debt to EBITDA
0.70 0.63 0.96 1.22 1.53 2.17 2.22 2.45 2.71 2.34
Net Debt to EBITDA
0.26 -0.01 -0.27 -0.52 -0.92 -1.69 -1.41 -1.64 -2.13 -1.67
Long-Term Debt to EBITDA
0.70 0.63 0.96 1.22 1.53 2.17 2.22 2.45 2.71 2.34
Debt to NOPAT
0.98 0.89 1.39 1.82 2.39 3.58 3.68 4.41 5.38 4.48
Net Debt to NOPAT
0.36 -0.02 -0.40 -0.78 -1.44 -2.78 -2.35 -2.95 -4.22 -3.20
Long-Term Debt to NOPAT
0.98 0.89 1.39 1.82 2.39 3.58 3.68 4.41 5.38 4.48
Altman Z-Score
4.58 4.62 4.16 4.01 3.72 3.82 3.84 3.61 3.58 3.61
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
4.24 5.11 4.88 4.65 4.37 5.13 4.71 4.88 4.58 4.85
Quick Ratio
2.16 2.61 2.96 2.91 2.86 3.43 3.09 3.22 3.12 3.13
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-48 26 206 291 266 196 82 60 49 -20
Operating Cash Flow to CapEx
1,180.51% 935.43% 991.70% 1,298.64% 1,604.76% 897.83% -585.24% 567.67% 838.76% 92.70%
Free Cash Flow to Firm to Interest Expense
-4.60 0.00 26.79 0.00 0.00 0.00 17.80 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
13.65 0.00 11.57 0.00 0.00 0.00 -6.73 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
12.50 0.00 10.41 0.00 0.00 0.00 -7.88 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
3.34 3.17 2.58 2.30 2.10 2.07 1.97 1.92 1.85 1.90
Accounts Receivable Turnover
12.97 15.06 9.91 9.83 9.94 13.07 10.44 10.63 10.27 13.00
Inventory Turnover
7.61 7.44 6.73 6.09 6.03 6.30 6.52 6.81 6.98 7.04
Fixed Asset Turnover
0.00 0.00 20.45 18.10 16.19 14.53 13.96 13.63 13.09 12.42
Accounts Payable Turnover
17.68 21.82 16.07 13.56 13.21 16.86 14.59 13.58 12.66 15.01
Days Sales Outstanding (DSO)
28.14 24.24 36.81 37.15 36.71 27.93 34.96 34.35 35.56 28.08
Days Inventory Outstanding (DIO)
47.96 49.08 54.24 59.96 60.58 57.91 55.98 53.59 52.28 51.83
Days Payable Outstanding (DPO)
20.65 16.73 22.72 26.92 27.62 21.65 25.02 26.87 28.82 24.31
Cash Conversion Cycle (CCC)
55.46 56.59 68.33 70.19 69.67 64.18 65.92 61.07 59.01 55.59
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
692 584 527 498 455 406 466 455 424 436
Invested Capital Turnover
7.21 7.72 6.38 5.61 5.71 6.34 6.17 6.33 6.72 7.01
Increase / (Decrease) in Invested Capital
115 14 -182 -261 -237 -177 -61 -42 -31 30
Enterprise Value (EV)
711 636 532 727 563 765 955 609 660 659
Market Capitalization
576 643 616 852 739 993 1,142 806 891 869
Book Value per Share
$60.08 $65.30 $67.42 $68.52 $70.14 $72.35 $75.41 $75.31 $76.90 $77.13
Tangible Book Value per Share
$53.71 $55.30 $57.57 $58.81 $60.46 $62.52 $65.59 $65.60 $67.14 $67.32
Total Capital
921 882 904 916 925 928 947 947 950 942
Total Debt
363 292 293 293 293 294 294 294 295 295
Total Long-Term Debt
363 292 293 293 293 294 294 294 295 295
Net Debt
134 -6.52 -83 -125 -176 -228 -187 -197 -232 -211
Capital Expenditures (CapEx)
12 16 8.97 4.94 4.84 8.42 5.32 6.31 7.36 20
Debt-free, Cash-free Net Working Capital (DFCFNWC)
656 567 509 474 433 380 442 430 397 395
Debt-free Net Working Capital (DFNWC)
885 866 885 893 903 902 924 921 924 900
Net Working Capital (NWC)
885 866 885 893 903 902 924 921 924 900
Net Nonoperating Expense (NNE)
7.44 8.18 6.09 5.25 4.49 37 3.51 3.61 1.77 3.83
Net Nonoperating Obligations (NNO)
134 -6.52 -83 -125 -176 -228 -187 -197 -232 -211
Total Depreciation and Amortization (D&A)
6.04 7.01 7.06 7.30 7.44 7.63 8.78 9.47 8.88 8.75
Debt-free, Cash-free Net Working Capital to Revenue
14.33% 12.75% 12.90% 13.47% 13.25% 12.12% 14.43% 14.25% 13.45% 13.37%
Debt-free Net Working Capital to Revenue
19.34% 19.47% 22.44% 25.34% 27.60% 28.75% 30.13% 30.53% 31.26% 30.49%
Net Working Capital to Revenue
19.34% 19.47% 22.44% 25.34% 27.60% 28.75% 30.13% 30.53% 31.26% 30.49%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$6.44 $3.95 $1.96 $2.70 $2.72 ($1.98) $2.02 $1.65 $1.88 $0.67
Adjusted Weighted Average Basic Shares Outstanding
9.04M 9.06M 9.09M 9.00M 8.77M 8.65M 8.66M 8.53M 8.38M 8.29M
Adjusted Diluted Earnings per Share
$6.38 $4.46 $1.94 $2.70 $2.71 ($1.96) $2.00 $1.65 $1.87 $0.67
Adjusted Weighted Average Diluted Shares Outstanding
9.04M 9.06M 9.09M 9.00M 8.77M 8.65M 8.66M 8.53M 8.38M 8.29M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
9.04M 9.06M 9.09M 9.00M 8.77M 8.65M 8.66M 8.53M 8.38M 8.29M
Normalized Net Operating Profit after Tax (NOPAT)
67 40 24 30 29 19 21 18 18 9.11
Normalized NOPAT Margin
6.31% 4.74% 3.00% 3.64% 3.56% 2.67% 2.89% 2.34% 2.38% 1.28%
Pre Tax Income Margin
7.60% 4.80% 3.04% 3.94% 4.13% -1.13% 3.17% 2.48% 2.89% 0.98%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
8.72 0.00 4.15 0.00 0.00 0.00 5.98 0.00 0.00 0.00
NOPAT to Interest Expense
6.41 0.00 3.11 0.00 0.00 0.00 4.54 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
7.56 0.00 2.99 0.00 0.00 0.00 4.83 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
5.25 0.00 1.94 0.00 0.00 0.00 3.39 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
19.66% 22.43% 0.00% 8.67% 29.72% 86.81% 0.00% 118.32% 144.00% 85.28%

Frequently Asked Questions About BlueLinx's Financials

When does BlueLinx's fiscal year end?

According to the most recent income statement we have on file, BlueLinx's financial year ends in December. Their financial year 2024 ended on December 28, 2024.

How has BlueLinx's net income changed over the last 2 years?

BlueLinx's net income appears to be on a downward trend, with a most recent value of $53.12 million in 2024, falling from $296.18 million in 2022. The previous period was $48.54 million in 2023.

What is BlueLinx's operating income?
BlueLinx's total operating income in 2024 was $87.57 million, based on the following breakdown:
  • Total Gross Profit: $489.14 million
  • Total Operating Expenses: $401.57 million
How has BlueLinx revenue changed over the last 2 years?

Over the last 2 years, BlueLinx's total revenue changed from $4.45 billion in 2022 to $2.95 billion in 2024, a change of -33.7%.

How much debt does BlueLinx have?

BlueLinx's total liabilities were at $931.28 million at the end of 2024, a 3.1% increase from 2023, and a 3.5% increase since 2022.

How much cash does BlueLinx have?

In the past 2 years, BlueLinx's cash and equivalents has ranged from $298.94 million in 2022 to $521.74 million in 2023, and is currently $505.62 million as of their latest financial filing in 2024.

How has BlueLinx's book value per share changed over the last 2 years?

Over the last 2 years, BlueLinx's book value per share changed from 65.30 in 2022 to 77.13 in 2024, a change of 18.1%.

Remove Ads


This page (NYSE:BXC) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners